Ingenieurwissenschaften und zugeordnete Tätigkeiten
Filtern
Erscheinungsjahr
- 2021 (3) (entfernen)
Dokumenttyp
- Sonstiges (3) (entfernen)
Referierte Publikation
- nein (3)
Schlagworte
- SDS-PAGE (2)
- ACE2-Rezeptor (1)
- ADC (1)
- Affinity (1)
- Analytical services (1)
- Antibody drug conjugate (1)
- Antikörper (1)
- COVID-19 (1)
- Catalogue of services (1)
- Click chemistry (1)
- Copper-catalyzed (1)
- Corona (1)
- DM1 (1)
- E. coli (1)
- EC4SafeNano (1)
- ELISA (1)
- European Centre (1)
- Expression (1)
- Fingerprint (1)
- HPLC (1)
- Halomonas elongata (1)
- Herceptin (1)
- Human antibody (1)
- Linker (1)
- MALDI-TOF-MS (1)
- MMAE (1)
- MST (1)
- Mertansine (1)
- Monomethyl Auristatin E (1)
- Nano-safety (1)
- Nanobody (1)
- Nanomaterials (1)
- Payload (1)
- Peptide (1)
- Periplasma (1)
- RBD (1)
- SARS-CoV-2 (1)
- SPR (1)
- Site-selective bioconjugation (1)
- Spike-Protein (1)
- Toxin (1)
- Trastuzumab (1)
- Vhh (1)
- Virus (1)
Organisationseinheit der BAM
- 1 Analytische Chemie; Referenzmaterialien (3) (entfernen)
Vergleichende Darstellung SARS-CoV-2-spezifischer Nanobodys aus unterschiedlichen Wirtsorganismen
(2021)
Aufgrund der anhaltenden COVID-19-Pandemie werden neutralisierende Therapeutika benötigt. Eine Möglichkeit zur Behandlung stellt die Verwendung monoklonaler Anti-SARS-CoV-2-Immun-globuline dar. Ihre Produktion in Säugetierzellen ist jedoch schwer skalierbar, um den weltweiten Bedarf zu decken. VHH-Antikörper, auch Nanobodys genannt, bieten hierfür eine Alternative, da sie eine hohe Temperaturstabilität aufweisen und eine kostengünstige Produktion in prokaryotischen Wirtsorganismen ermöglichen.
Development of an affinity-based method for the site-selective synthesis of antibody-drug-conjugates
(2021)
For the site-selective synthesis of ADCs, a variety of obstacles must be overcome. Those include designing bifunctional affinity peptides with reasonably low 𝐾𝑑-values that couple to the mAb in a site-selective manner. These peptides should also include a functional group that links the payload to the mAb under mild conditions without adversely affecting it. The bioconjugation between peptide and antibody and the linker between peptide and payload must be stable and durable to provide safety when used for medical purposes. The usage of metals and organic solvents should be minimized. Within the project, new types of functionalized affinity peptides were designed, and their affinity towards the Fc-fragment was determined.
The publicly available document encapsulates the first version of the Catalogue of Services of the future EC4Safenano Centre (CoS 2019).
The CoS 2019 is structured in 12 Service Categories and 27 Service Topics, for each of the 12 categories considered. This architecture configures a 12 x 27 matrix that allows ordering the potential EC4Safenano offer in 324 types of services/groups of services.
Each type of service/group of services is described, in a simple and friendly way, by means of a specific service sheet: the EC4Safenano - Service Data Sheet (EC4-SDS). These EC4-SDSs allow structuring and summarizing the information of each service, providing the customer with a concise view of characteristics of the service and also the contact details with the service provider.
The CoS 2019 deploys a map of services consisting of a set of 100 EC4-SDSs, covering 7 of the 12 Service Categories and 17 of the 27 Service Topics.
The harmonization of services is visualized as a future necessary step in EC4Safenano, in order to strengthen the offer and provide added value to customers with a growing offer of harmonized services in future versions of the CoS.
The information contained in this document is structured in 3 main sections, as follows:
• Catalogue structure. This section describes in short the main characteristics of the CoS 2019.
• Catalogue content. This section represents the core part of the document and encapsulates the set of 100 SDSs displaying the offer proposed by the CoS 2019.
• Online Catalogue. This section describes the resources implemented by EC4Safenano to facilitate the on-line consultation of the CoS 2019 by customers and other interested parties.